Results 151 to 160 of about 84,453 (255)

Semiochemical interruption of Dendroctonus rufipennis (Coleoptera: Curculionidae) in Alaska and Colorado, U.S. [PDF]

open access: yesJ Econ Entomol
Audley JP   +6 more
europepmc   +1 more source

Synthesis of Dithienylcycloalkene Molecular Switches Enabled by a Bench‐Stable Ti‐Complex

open access: yesChemistry – A European Journal, EarlyView.
Herein we report a set of cycloalkene‐bridged DTEs with ring sizes ranging from 4‐ to 7‐membered rings. The synthesis of these analogs was performed via a key McMurry coupling step, which was enabled by a practical, bench‐stable Ti(IV)‐complex. Remarkably, it is shown that the strained cyclobutene bridge outperforms other rings, even the most commonly ...
Marcell M. Bogner   +4 more
wiley   +1 more source

Application of FreezeTB, a targeted nanopore sequencing assay, for identification of drug resistance and lineages among pulmonary tuberculosis cases in Alaska. [PDF]

open access: yesMicrobiol Spectr
Inman B   +12 more
europepmc   +1 more source

Chemotherapeutic Potential of Fluorouracil‐Platinum (IV) Prodrugs Against Cisplatin‐Resistant Colorectal Cancer Cells

open access: yesChemistry – A European Journal, EarlyView.
ABSTRACT Fluorouracil‐platinum(IV) prodrugs represent a novel class of multimechanistic chemotherapeutics with enhanced anticancer potential. The prodrugs PtIVP‐5FUMeOBut and PtIV56‐5FUMeOBut were actualized by derivatising the clinical drug 5‐fluorouracil (5FU) and coordinating it to platinum(IV) complexes, leveraging the established cytotoxicity of ...
Maria George Elias   +9 more
wiley   +1 more source

Care coordination and communication for Native American patients with cancer. [PDF]

open access: yesOncologist
Daley MP   +13 more
europepmc   +1 more source

Clinical Study to Evaluate Drug Interactions of Cannabidiol with Citalopram and Morphine in Healthy Adults

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Cannabidiol (CBD) is one of the most abundant bioactive cannabinoids. Research has demonstrated CBD’s ability to inhibit metabolic enzymes like cytochrome P450 (CYP) and UDP‐glucuronosyltransferase (UGT), potentially leading to drug interactions. However, clinical knowledge gaps remain, particularly with regard to drugs that are more commonly taken by ...
Pablo Salcedo   +11 more
wiley   +1 more source

Building a Robust Investigator‐Initiated Platform: The I‐CARE Experience

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Investigator‐initiated studies that include information collected by patients are rising, but limited data is available on patient and investigator experience in this setting. The I‐CARE cohort included patients with inflammatory bowel disease (IBD) monthly collecting clinical information in 15 countries for up to 6 years.
Julien Kirchgesner   +906 more
wiley   +1 more source

Learning Strategies from Nature's Blueprint to Cyclic Carbonate Synthesis

open access: yesChemSusChem, Volume 18, Issue 6, March 15, 2025.
The development of sustainable synthetic methods for cyclic carbonates draws inspiration from nature, focusing on eco‐friendly processes and renewable resources like CO2 and biomass. This review explore various CO2 activation mechanisms, green chemistry principles, and green catalysts.
Erika Saccullo   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy